Nalaganje...
Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
BACKGROUND: The efficacy of neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (BCa) was established primarily with methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC), with complete response rates (pT0) as high as 38%. However, because of the comparable efficacy with better...
Shranjeno v:
| izdano v: | Eur Urol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4840190/ https://ncbi.nlm.nih.gov/pubmed/25257030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.09.007 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|